| CD31 | Cluster of differentiation 31 |
| CDK11A | Cyclin Dependent kinase 11A |
| CDK15 | Cyclin Dependent kinase 15 |
| CDK4 | Cyclin-dependent kinase 4 |
| CDK9 | Cyclin-dependent kinase 9 |
| CDKL1 | Cyclin-dependent kinase-like 1 |
| CLK3 | CDC Like kinase 3 |
| CIL | Cilastatin |
| CIPN | Chemotherapy-induced peripheral neuropathy |
| CRC | Colorectal cancer |
| DPEP1 | Dipeptidase 1 |
| DRG | Dorsal root ganglia |
| FANCG | Fanconi anemia group G protein |
| FKBP51 | FK506-binding protein 51 |
| GFAP | Glial fibrillary acidic protein |
| GR | Glucocorticoid receptor |
| IKK | IkB kinase |
| IL-6 | Interleukin 6 |
| MCC | Manders’ coefficient |
| MOS | Proto-oncogene serine/threonine-protein kinase |
| NCAPD2 | Non-SMC condensin I complex subunit D2 |
| NCAPG | Non-SMC condensin I complex subunit G |
| NCAPH | Non-SMC condensin I complex subunit H |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| OIPN | Oxaliplatin-induced peripheral neuropathy |
| ORC5 | Origin recognition complex subunit 5 |
| OxPt | Oxaliplatin |
| PCC | Pearson’s coefficient |
| PFA | Paraformaldehyde |
| PIPOX | Pipecolic acid and sarcosine oxidase |
| PPIase | Peptidyl-prolyl-(cis/trans)-isomerase |
| PSKH2 | Protein serine/threonine-protein kinase H2 |
| ROI | Region of interest |
| SMC2 | Structural maintenance of chromosomes 2 |
| SMC4 | Structural maintenance of chromosomes 4 |
| STK11 | Serine/threonine kinase 11 |
| SUN1 | Sad1 and UNC-84 domain-containing protein 1 |
| TNFα | Tumor necrosis factor alpha |
| ULK3 | Unc-51 like kinase 3 |
| VDAC1 | Voltage-dependent anion-selective channel 1 |
| WDR90 | WD repeat domain 90 |